Marino Garcia's Insider Trades & SAST Disclosures

Marino Garcia's most recent trade in Dianthus Therapeutics Inc was a trade of 340,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Dianthus Therapeutics Inc
Marino Garcia Director, CEO AND PRESIDENT Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 340,000 340,000 - - Stock Option (Right to Buy)
Dianthus Therapeutics Inc
Marino Garcia Director, CEO AND PRESIDENT Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 243,000 243,000 - - Stock Option (Right to Buy)
Dianthus Therapeutics Inc
Marino Garcia Director, CEO AND PRESIDENT Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 275,000 275,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades